Synthesis of riboflavines, quinoxalinones and benzodiazepines through chemoselective flow based hydrogenations

Molecules

Volumn 19, Issue 7, 2014, Pages 9736-9759

  Baumann, Marcus ^a,b   Baxendale, Ian R ^a,b   Hornung, Christian H ^b   Ley, Steven V ^b   Rojo, Maria Victoria ^b   Roper, Kimberley A ^b  

^a DURHAM UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Benzodiazepine; Flow chemistry; Hydrogenation; Micro reactor; Riboflavine

Indexed keywords

BENZODIAZEPINE DERIVATIVE; RIBOFLAVIN;

ANALOGS AND DERIVATIVES; CHEMISTRY; HYDROGENATION; SYNTHESIS;

BENZODIAZEPINES; HYDROGENATION; RIBOFLAVIN;

EID: 84904812579     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19079736     Document Type: Article

References (63)

1. Silverman, R.B. The Organic Chemistry of Drug Design and Drug Action, 2nd ed.; Academic Press: San Diego, CA, USA, 2004.
2. Li, J.-J.; Johnson, D.S.; Sliskovich, D.R.; Roth, B.D. Contemporary Drug Synthesis; John Wiley and Sons: Chichester, UK, 2004.
3. Wermuth, C.G. The Practice of Medicinal Chemistry, 3rd ed.; Elsevier Academic Press: Burlington, MA, USA, 2008.
4. Baumann, M.; Baxendale, I.R.; Ley, S.V.; Nikbin, N. An overview of the key routes to the best selling 5-membered ring heterocyclic pharmaceuticals. Beilstein J. Org. Chem. 2011, 7, 442-496.
5. Baumann, M.; Baxendale, I.R. An overview of the synthetic routes to the best selling drugs containing 6-membered heterocycles. Beilstein J. Org. Chem. 2013, 9, 2265-2319.
6. Li, J.-J. Heterocyclic Chemistry in Drug Discovery, 1st ed.; John Wiley & Sons: Hoboken, NJ, USA, 2013.
7. Scannel, J.W.; Blanckley, A.; Boldon, H.; Warrington, B. Diagnosing the decline in pharmaceutical R&D efficiency. Nat. Rev. Drug Discov. 2012, 11, 191-200.
8. Baxendale, I.R.; Hayward, J.J.; Ley, S.V.; Tranmer, G.K. Pharmaceutical strategy and innovation: An academics perspective. Chem Med Chem 2007, 2, 768-788.
9. Wild, H.; Heimbach, D.; Huwe, C. The importance of chemistry for the future of the pharma industry. Angew. Chem. Int. Ed. 2011, 50, 7452-7453.
10. Wegner, J.; Ceylan, S.; Kirschning, A. Ten key issues in modern flow chemistry. Chem. Commun. 2011, 47, 4583-4592.
11. Tierney, J.P.; Lidström, P. Microwave Assisted Organic Synthesis; Blackwell CRC Press: Oxford, UK, 2005.
12. Yoshida, J. Flash Chemistry: Fast Organic Synthesis in Microsystems; John Wiley & Sons: Chichester, UK, 2008.
13. Razzaq, T.; Kappe, C.O. Continuous flow organic synthesis under high- Temperature/pressure conditions. Chem.-Asian J. 2010, 5, 1274-1289.
14. Noël, T.; Naber, J.R.; Hartman, R.L.; McMullen, J.P.; Jensen, K.F.; Buchwald, S.L. Palladium-catalyzed amination reactions in flow: Overcoming the challenges of clogging via acoustic irradiation. Chem. Sci. 2011, 2, 287-290.
15. Ceylan, S.; Coutable, L.; Wegner, J.; Kirschning, A. Inductive heating with magnetic materials inside flow reactors. Chem.-Eur. J. 2011, 17, 1884-1893.
16. Rasheed, M.; Wirth, T. Intelligent microflow: Development of self-optimizing reaction systems. Angew. Chem. Int. Ed. 2010, 50, 357-358.
17. Wiles, C.; Watts, P. Recent advances in micro reaction technology. Chem. Commun. 2011, 47, 6512-6535.
18. Ley, S.V. On being green: Can flow chemistry help? Chem. Rec. 2012, 378-390.
19. Hartman, R.L.; McMullen, J.P.; Jensen, K.F. Deciding whether to go with the flow: Evaluating the merits of flow reactors for synthesis. Angew. Chem. Int. Ed. 2011, 50, 7502-7519.
20. Wiles, C.; Watts, P. Continuous flow reactors: A perspective. Green Chem. 2012, 14, 38-54.
21. Wegner, J.; Ceylan, S.; Kirschning, A. Flow chemistry- A key enabling technology for (multistep) organic synthesis. Adv. Synth. Catal. 2012, 354, 17-57.
22. Malet-Sanz, L.; Susanne, F. Continuous flow synthesis. A pharma perspective. J. Med. Chem. 2012, 55, 4062-4098.
23. Baxendale, I.R. The integration of flow reactors into synthetic organic chemistry. J. Chem. Technol. Biot. 2013, 88, 519-552.
24. Baumann, M.; Baxendale, I.R.; Ley, S.V. The flow synthesis of heterocycles for natural product and medicinal chemistry applications. Mol. Divers. 2011, 15, 613-630.
25. Glasnov, T.N.; Kappe, C.O. Toward a continuous-flow synthesis of Boscalid®. Adv. Synth. Catal. 2010, 352, 3089-3097.
26. Baxendale, I.R.; Deeley, J.; Griffiths-Jones, C.M.; Ley, S.V.; Saaby, S.; Tranmer, G.K. A flow process for the multi-step synthesis of the alkaloid natural product oxomaritidine. Chem. Commun. 2006, 2566-2568.
27. Baumann, M.; Baxendale, I.R.; Ley, S.V.; Nikbin, N.; Smith, C.D.; Tierney, J.P. A modular flow reactor for performing Curtius rearrangements as a continuous flow process. Org. Biomol. Lett. 2008, 6, 1577-1586.
28. 2 in a tube-in- Tube gas-permeable membrane reactor. Angew. Chem. Int. Ed. 2011, 50, 1190-1193.
29. Browne, D.L.; Baumann, M.; Harji, B.H.; Baxendale, I.R.; Ley, S.V. A new enabling technology for convenient laboratory scale continuous flow processing at low temperatures. Org. Lett. 2011, 13, 3312-3315.
30. Hopkin, M.D.; Baxendale, I.R.; Ley, S.V. An expeditious synthesis of Imatinib and analogues utilising flow chemistry methods. Org. Biomol. Chem. 2013, 11, 1822-1839.
31. Hu, D.X.; O'Brien, M.; Ley, S.V. Continuous multiple liquid-liquid separation: Diazotization of amino acids in flow. Org. Lett. 2012, 14, 4246-4249.
32. Baxendale, I.R.; Ley, S.V.; Mansfield, A.C.; Smith, C.D. Multi-step synthesis using modular flow reactors: Bestmann-Ohira reagent for the formation of alkynes and triazoles. Angew. Chem. Int. Ed. 2009, 48, 3287-3289.
33. Malet-Sanz, L.; Madrzak, J.; Ley, S.V.; Baxendale, I.R. Preparation of arylsulfonyl chlorides by chlorosulfonylation of in-situ generated diazonium salts using a continuous flow reactor. Org. Biomol. Chem. 2010, 8, 5324-5332.
34. 4 mediated oxidation as a continuous flow process. Org. Lett. 2010, 12, 3618-3621.
35. Qian, Z.; Baxendale, I.R.; Ley, S.V. A continuous flow process using a sequence of microreactors with in-line IR analysis for the preparation of N, N-diethyl-4-(3-fluorophenylpiperidin-4-ylidenemethyl)benzamide as a potent and highly selective δ-opioid receptor. Chem.-Eur. J. 2010, 16, 12342-12348.
36. Venturoni, F.; Nikbin, N.; Ley, S.V.; Baxendale, I.R. The application of flow microreactors to the preparation of a family of casein kinase I inhibitors. Org. Biomol. Chem. 2010, 8, 1798-1806.
37. Baxendale, I.R.; Schou, S.C.; Sedelmeier, J.; Ley, S.V. Multi-Step synthesis by using modular flow reactors: The preparation of yne-ones and their use in heterocycle synthesis. Chem.-Eur. J. 2010, 16, 89-94.
38. Smith, C.J.; Nikbin, N.; Ley, S.V.; Lange, H.; Baxendale, I.R. A fully automated, multistep flow synthesis of 5- Amino-4-cyano-1, 2, 3- Triazoles. Org. Biomol. Chem. 2011, 9, 1938-1947.
39. Guetzoyan, L.; Nikbin, N.; Baxendale, I.R.; Ley, S.V. Flow chemistry synthesis of Zolpidem, Alpidem and other GABAA agonists and their biological evaluation through the use of in-line frontal affinity chromatography. Chem. Sci. 2013, 4, 764-769.
40. Battilocchio, C.; Deadman, B.J.; Nikbin, N.; Kitching, M.O.; Baxendale, I.R.; Ley, S.V. A machine- Assisted flow synthesis of SR48692: A probe for the investigation of neurotensin receptor-1. Chem.-Eur. J. 2013, 19, 7917-7930.
41. Baumann, M.; Baxendale, I.R.; Ley, S.V. Synthesis of 3-nitropyrrolidines via dipolar cycloaddition reactions using a modular flow reactor. Synlett 2010, 749-752.
42. Baumann, M.; Baxendale, I.R.; Wegner, J.; Kirschning, A.; Ley, S.V. Synthesis of highly substituted nitropyrrolidines, nitropyrrolizines and nitropyrroles via multicomponent-multistep sequences within a flow reactor. Heterocycles 2010, 82, 1297-1316.
43. Baumann, M.; Martin, R.E.; Kuratli, C.; Schneider, J.; Baxendale, I.R.; Ley, S.V. Synthesis of a drug-like focused library of trisubstituted pyrrolidines using integrated flow chemistry and batch methods. ACS Comb. Sci. 2011, 13, 405-413.
44. Granados-Soto, V.; Terán-Rosales, F.; Rocha-González, H.I.; Reyes-García, G.; Medina-Santillán, R.; Rodríguez- Silverio, J. Riboflavin reduces hyperalgesia and inflammation but not tactile allodynia in the rat. Eur. J. Pharmacol. 2004, 492, 35-40.
45. Banekovich, C.; Ott, I.; Koch, T.; Mutuszczak, B.; Gust, R. Synthesis and biological activities of novel dexibuprofen tetraacetylriboflavin conjugates. Biol. Med. Chem. Lett. 2007, 17, 683-687.
46. Cowden, W.B.; Halladay, P.K.; Cunningham, R.B.; Hunt, N.H.; Cleak, I.A. Flavins as potential antimalarials. 2. 3-Methyl-10-(substituted-phenyl)flavins. J. Med. Chem. 1991, 34, 1818-1822.
47. Shorter, E. Benzodiazepines. A Historical Dictionary of Psychiatry; Oxford University Press: Oxford, UK, 2005.
48. Page, C.; Michael, C.; Sutter, M.; Walker, M.; Hoffman, B.B. Integrated Pharmacology, 3rd ed.; Elsevier: London, UK, 2006.
49. Olkkola, K.T.; Ahonen, J. Midazolam and other benzodiazepines. In Handbook of Experimental Pharmacology; Barrett, J.E., Flockerzi, V., Geppetti, P., Hofmann, F.B., Michel, M.C., Moore, P., Page, C.P., Eds.; Spring: Berlin, Germany, 2008; Volume 182, pp. 335-360.
50. McGrath, N.A.; Brichacek, M.; Njardarson, J.T. A graphical journey of innovative organic architectures that have improved our lives. J. Chem. Educ. 2010, 87, 1348-1349.
51. Ilardi, E.A.; Vitaku, E.; Njardarson, J.T. An in-pharm- Ative educational poster anthology highlighting the therapeutic agents that chronicle our medicinal history. J. Chem. Educ. 2013, 90, 1403.
52. Tishler, M.; Pfister, K.; Babson, R.D.; Ladenburg, K.; Fleming, A.J. The reaction between o- Aminoazo compounds and barbituric acid. A new synthesis of riboflavin. J. Am. Chem. Soc. 1947, 69, 1487-1492.
53. Yoneda, F.; Sakuma, Y.; Ichiba, M.; Shinomura, K. Syntheses of isoalloxazines and isoalloxazine 5-oxides. A new synthesis of riboflavin. J. Am. Chem. Soc. 1976, 98, 830-835.
54. Cresswell, R.M.; Hill, A.C.; Wood, H.C.S. 140. Pteridine derivatives. Part VII. The synthesis of riboflavin 2-imine and related isoalloxazine 2-imines. J. Chem. Soc. 1959, 698-704.
55. Cresswell, R.M.; Neilson, T.; Wood, H.C.S. Pteridine Derivatives. Part VI11. A new synthesis of riboflavin and related isoalloxaxines. J. Chem. Soc. 1961, 476-477.
56. Villemin, D.; Martin, B. Synthesis of quinoxalines under focussed microwave irradiation. Synth. Commun. 1995, 25, 2319-2326.
57. Karrer, P.; Meerwein, H.F. Ein emodifizierte Flavinsynthese. Helv. Chim. Acta 1935, 18, 1130-1134.
58. Hunziker, F.; Kunzle, F.; Schmutz, J.; Schindler, O. Dibenzo- Azepine, -diazepine, -oxazepine und- Thiazepine. 3. Mitteilung über siebengliedrige Heterocyclen. Helv. Chim. Acta 1964, 47, 1163-1172.
59. Hunziker, F.; Fischer, E.; Schmutz, J. 11-Amino-5H-dibenzo[b, e]-1, 4-diazepine. 10. Mitteilung über siebengliedrige Heterocyclen. Helv. Chim. Acta 1967, 50, 1588-1599.
60. Schmutz, J.; Kunzle, F.; Hunziker, F.; Gauch, R. Über in 11-Stellung aminosubstituierte Dibenzo[b, f]-1, 4- Thiazepine und -oxazepine. 9. Mitteilung über siebengliedrige Heterocyclen. Helv. Chim. Acta 1967, 50, 245-254.
61. Rampe, D.; Triggle, D.J. Benzodiazepines and calcium channel function. Trends Pharmacol. Sci. 1986, 5, 461-464.
62. Nutt, D. Benzodiazepine dependence in the clinic: Reason for anxiety? Trends Pharmacol. Sci. 1986, 7, 457-460.
63. Richter, L.; de Graaf, C.; Sieghart, W.; Varagic, Z.; Mörzinger, M.; de Esch, I.J.P.; Ecker, G.F.; Ernst, M. Diazepam-bound GABAA receptor models identify new benzodiazepine binding-site ligands. Nat. Chem. Biol. 2012, 8, 455-464.